Skip to main content
. 2024 Feb 21;16(2):e54622. doi: 10.7759/cureus.54622

Table 4. Groupwise distribution of adverse effects.

#Statistically significant

HR: heart rate, bpm: beats per minute

Adverse effect Group A (n = 157) Group B (n = 160) p-value
Tachycardia (HR > 100 bpm) 11 21 0.105
Hypotension 12 2 0.0058#
Bradycardia 0 1 1.0
Palpitation 7 13 0.266
Arrhythmias 0 0 Not applicable
Nausea 3 23 0.000046#
Vomiting 1 7 0.067
Constipation 3 8 0.219
Shivering 9 1 0.01#
Headache 1 2 1.0
Backache 4 0 0.059
Numbness 3 0 0.120